ILC Therapeutics

ILC Therapeutics is an emerging biotechnology company focused on modulating the innate immune system through the design and development of novel hybrid interferon candidates. The company is developing a new type of interferon drug, known as hybrid interferons. These molecules incorporate the characteristics of natural interferon subtypes and combine them into a new hybrid interferon molecule. These new molecules are designed to provide enhanced efficacy and improved safety across a range of high-value therapeutic areas, creating life-changing outcomes for patients.